Cover image not available

Azacitidine for the treatment of myelodysplastic syndromes, chronic myelomonocytic leukaemia and acute myeloid leukaemia

National Institute for Health and Clinical Excellence

Publication Data

Title Azacitidine for the treatment of myelodysplastic syndromes, chronic myelomonocytic leukaemia and acute myeloid leukaemia
Author National Institute for Health and Clinical Excellence
Publisher National Institute for Health and Clinical Excellence
Publication date 2011
Publication location London
Language English

Descriptive Notes

Issue date: March 2011.
"The guidance was developed using the NICE single technology appraisal process."
Publisher's number: N2491.

Topics

Myelodysplastic syndromes :: Chemotherapy
Leukemia :: Chemotherapy
Azacitidine

Catalogue Data

OBNB ID GBB586111
ISBN 10 n/a
ISBN 13 n/a
Type BibliographicResource, Book
Dewey Classification 616.99419061

ISBD

P1053 1 online resource (2 unnumbered pages).
P1042 Includes bibliographical references.

Buy a copy

OBNB doesn't sell books, but you may be able to find a copy at one of these websites:

Azacitidine for the treatment of myelodysplastic syndromes, chronic myelomonocytic leukaemia and acute myeloid leukaemia by National Institute for Health and Clinical Excellence. Published by National Institute for Health and Clinical Excellence in 2011. Publication and catalogue information, links to buy online and reader comments.